Medipower M Stock Net Income
| MDPR Stock | ILS 658.40 4.00 0.61% |
As of the 30th of January, Medipower secures the Risk Adjusted Performance of 0.0213, mean deviation of 1.72, and Downside Deviation of 2.43. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medipower M, as well as the relationship between them.
Medipower's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Medipower's valuation are provided below:Medipower M does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Medipower |
Medipower 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Medipower's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Medipower.
| 11/01/2025 |
| 01/30/2026 |
If you would invest 0.00 in Medipower on November 1, 2025 and sell it all today you would earn a total of 0.00 from holding Medipower M or generate 0.0% return on investment in Medipower over 90 days. Medipower is related to or competes with Netanel, Polygon L, Maslavi, Av Gad, Mishorim Real, Aspen, and Ravad. Limited owns and manages retail properties and residential developments in the United States, Canada, and Bulgaria More
Medipower Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Medipower's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Medipower M upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.43 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 10.6 | |||
| Value At Risk | (3.84) | |||
| Potential Upside | 3.58 |
Medipower Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medipower's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Medipower's standard deviation. In reality, there are many statistical measures that can use Medipower historical prices to predict the future Medipower's volatility.| Risk Adjusted Performance | 0.0213 | |||
| Jensen Alpha | 0.0322 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.5798 |
Medipower January 30, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0213 | |||
| Market Risk Adjusted Performance | 0.5898 | |||
| Mean Deviation | 1.72 | |||
| Semi Deviation | 2.26 | |||
| Downside Deviation | 2.43 | |||
| Coefficient Of Variation | 4988.87 | |||
| Standard Deviation | 2.26 | |||
| Variance | 5.12 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | 0.0322 | |||
| Total Risk Alpha | (0.12) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.5798 | |||
| Maximum Drawdown | 10.6 | |||
| Value At Risk | (3.84) | |||
| Potential Upside | 3.58 | |||
| Downside Variance | 5.92 | |||
| Semi Variance | 5.11 | |||
| Expected Short fall | (1.67) | |||
| Skewness | 0.0481 | |||
| Kurtosis | (0.07) |
Medipower M Backtested Returns
Medipower M has Sharpe Ratio of -0.0393, which conveys that the firm had a -0.0393 % return per unit of risk over the last 3 months. Medipower exposes thirty different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medipower's Downside Deviation of 2.43, risk adjusted performance of 0.0213, and Mean Deviation of 1.72 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.061, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medipower's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medipower is expected to be smaller as well. At this point, Medipower M has a negative expected return of -0.0778%. Please make sure to verify Medipower's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to decide if Medipower M performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.21 |
Weak reverse predictability
Medipower M has weak reverse predictability. Overlapping area represents the amount of predictability between Medipower time series from 1st of November 2025 to 16th of December 2025 and 16th of December 2025 to 30th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Medipower M price movement. The serial correlation of -0.21 indicates that over 21.0% of current Medipower price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.21 | |
| Spearman Rank Test | -0.08 | |
| Residual Average | 0.0 | |
| Price Variance | 231.42 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Medipower M reported net income of 9.19 M. This is 96.31% lower than that of the Real Estate Management & Development sector and 91.1% lower than that of the Real Estate industry. The net income for all Israel stocks is 98.39% higher than that of the company.
Medipower Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medipower's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medipower could also be used in its relative valuation, which is a method of valuing Medipower by comparing valuation metrics of similar companies.Medipower is currently under evaluation in net income category among its peers.
Medipower Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0343 | |||
| Profit Margin | 0.32 % | |||
| Operating Margin | 0.60 % | |||
| Current Valuation | 386.99 M | |||
| Shares Outstanding | 51.14 M | |||
| Shares Owned By Insiders | 53.26 % | |||
| Shares Owned By Institutions | 31.80 % | |||
| Price To Sales | 7.91 X | |||
| Revenue | 37.23 M | |||
| Gross Profit | 21.16 M | |||
| EBITDA | 11.35 M | |||
| Net Income | 9.19 M | |||
| Cash And Equivalents | 7.58 M | |||
| Cash Per Share | 0.20 X | |||
| Total Debt | 108.11 M | |||
| Debt To Equity | 141.30 % | |||
| Current Ratio | 1.39 X | |||
| Book Value Per Share | 2.29 X | |||
| Cash Flow From Operations | 9.5 M | |||
| Earnings Per Share | 0.12 X | |||
| Beta | 0.45 | |||
| Market Capitalization | 298.74 M | |||
| Total Asset | 100 M | |||
| Retained Earnings | 10 M | |||
| Working Capital | (15 M) | |||
| Current Asset | 7 M | |||
| Current Liabilities | 22 M | |||
| Z Score | 1.2 | |||
| Annual Yield | 0.03 % |
About Medipower Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medipower M's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medipower using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medipower M based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| VTI | Vanguard Total Stock | |
| RIOT | Riot Blockchain | |
| TSLA | Tesla Inc |
Other Information on Investing in Medipower Stock
Medipower financial ratios help investors to determine whether Medipower Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipower with respect to the benefits of owning Medipower security.